Previous studies with the herpes simplex virus type 1 x type 2 intertypic recombinant RS6 suggested that the genomic region from 0.11 to 0.14 map units is involved in neurovirulence (R. T. Javier, R. L. Thompson, and J. G. Stevens, J. Virol. 61:1978-1984 Herpes simplex virus type 1 (HSV-1) induces a lifethreatening encephalitis in humans (for a review, see reference 13), and there is a continuing interest in understanding the properties of the agent relating to this syndrome. To define various aspects of this disease, mice have served as an experimental model because after intracranial inoculation they succumb to very low doses of most HSV-1 or HSV-2 isolates. By exploiting this model to identify mutations in viral genes whose primary function is the enhancement of virulence within the central nervous system, it should ultimately be possible to establish molecular mechanisms underlying HSV-related neurovirulence.
Herpes simplex virus type 1 (HSV-1) induces a lifethreatening encephalitis in humans (for a review, see reference 13) , and there is a continuing interest in understanding the properties of the agent relating to this syndrome. To define various aspects of this disease, mice have served as an experimental model because after intracranial inoculation they succumb to very low doses of most HSV-1 or HSV-2 isolates. By exploiting this model to identify mutations in viral genes whose primary function is the enhancement of virulence within the central nervous system, it should ultimately be possible to establish molecular mechanisms underlying HSV-related neurovirulence.
Genetic analyses designed to identify specific neurovirulence-associated genes are limited by the availability of suitable mutant viruses, and to date, the viral thymidine kinase (TK) gene (4) and, more recently, the viral DNA polymerase gene (3) have been closely linked to HSVinduced central nervous system disease. To identify other viral genes associated with this property, we have been studying two HSV-1 x HSV-2 intertypic recombinants (RE6 and RS6) which exhibit phenotypes useful for the study of neurovirulence (6, 18) . Although attenuated for virulence and replication after intracranial inoculation of mice, these viruses express wild-type (wt) levels of thymidine kinase and replicate efficiently in nonneural mouse tissues. Using cloned wt HSV-1 DNA in marker rescue experiments, we found that genetic defects contributing to the reduced neurovirulence of both RE6 and RS6 are (6, 17) . Since increased neurovirulence of recombinant viruses derived from these two intertypic viruses is always associated with heterologous DNA replacements (HSV-2 DNA replaced with HSV-1 DNA) in specific genomic regions and since HSV-1 and HSV-2 DNA are easily distinguishable by restriction enzyme analysis, genetic studies using these intertypic viruses are greatly facilitated.
In a previous study with RS6 (6) , it was apparent that at least one other genetic defect was responsible for the avirulent phenotype of this virus. Thus, in marker rescue experiments (using unit-length RS6 DNA and total-genomic HSV-1 DNA fragments), only recombinant viruses in which RS6 HSV-2 DNA was replaced with HSV-1 DNA in both the regions from 0.79 to 0.83 m.u. and 0.11 to 0.14 m.u. exhibited wt neurovirulence. This observation suggested that the region from 0.11 to 0.14 m.u. also participated in HSV neurovirulence. Despite this, attempts to increase the neurovirulence of RS6 by using only a cloned HSV-1 DNA fragment spanning the region from 0.11 to 0.14 m.u. were unsuccessful (6; unpublished results), suggesting that repair of a more dominant genetic defect was required before the function of this region could be revealed. We now report the isolation and characterization of such a recombinant which retains the low-neurovirulence phenotype of RS6. (18) . Neurovirulence was measured by intracranial inoculation of mice because this route of infection is not influenced by the neuroinvasiveness of the virus (16) . Six-week-old outbred male Swiss Webster mice (Simonsen Laboratories) were used in all experiments, and standard procedures for intracranial inoculation (18, 19) and quantitation of neurovirulence (14) were used.
TK enzyme assay. The TK enzyme assay was a modification of that used by Jamieson and Subak-Sharpe (5 Standard methods for agarose gel electrophoresis, DNA transfer to nylon membranes, and preparation of cloned HSV DNA were used (10). Cloned DNA was nick translated in the presence of biotin-11-dUTP (Bethesda Research Laboratories, Inc.) and used in hybridization experiments as described previously (6) .
RESULTS
Reconfirming the significance of the region from 0.11 to 0.14 m.u. for neurovirulence, and isolation of virus R13-1. The importance of the genomic region from 0.11 to 0.14 m.u. for HSV neurovirulence was first suggested in a previous study (6) in which we found that one of two common genomic changes exhibited by recombinant viruses with wt neurovirulence characteristics was replacement of HSV-2 DNA with HSV-1 DNA between 0.11 and 0.14 m.u. One of these recombinant viruses (X3-13) exhibited a genomic structure in which a narrow region of HSV-2 DNA at 0.11 to 0.14 m.u. had been replaced with HSV-1 DNA (Fig. 1 ). To reconfirm that the region from 0.11 to 0.14 m.u. functioned in HSV neurovirulence, we used total genomic HindIII-digested X3-13 DNA in cotransfections with unit-length RS6 DNA. It was predicted that if the X3-13 HSV-1 region from 0.11 to 0.14 m.u. was essential for neurovirulence, then all resulting recombinant viruses with wt neurovirulence would have acquired this HSV-1 region from X3-13.
From 15 transfection plates, we were able to isolate 11 neurovirulence-enhanced recombinant viruses (each from a different plate), 7 of which displayed wt neurovirulence (data not shown). When examined by restriction enzyme analysis (data not shown), all seven of these viruses had gained the X3-13 HSV-1 region at 0.11 to 0.14 m.u., among other genomic changes, reconfirming the importance of this region for neurovirulence. Of greater significance, however, was the fact that one virus (R13-1) isolated in this experiment did not demonstrate the X3-13 HSV-1 region at 0.11 to 0.14 m.u. and was weakly neurovirulent (see below). The genomic structure of the intertypic recombinant virus R13-1 is illustrated in Fig. 1 .
Comparative phenotypes of R13-1, 17 syn+, and HG52. (i) LD50 after intracranial inoculation. To establish the neurovirulence of R13-1 relative to that of its wt virus counterparts (strains 17 syn+ and HG52), we inoculated 6-week-old male outbred Swiss Webster mice intracranially with 0.03 ml of serial 10-fold dilutions (five mice per dilution) of virus. Deaths resulting from encephalitis were scored for 21 days postinfection, and at the end of the experiment, 50% lethal doses (LD50s) were calculated by the method of Reed and Muench (14) . The LD50 of R13-1, 17 syn+, and HG,2 were 3.5 x 104, 2.0, and 1.3 PFU, respectively, indicating that R13-1 was approximately 10,000-times less neurovirulent than the wt viruses from which it was derived.
Since R13-1 had extensive genomic replacements of RS6 HSV-2 DNA with HSV-1 DNA, it was potentially a virus with a neurovirulence defect only in the region from 0.11 to 0.14 m.u. If this was so, we could more definitively establish the role of this genomic region in HSV neurovirulence and then functionally characterize the gene(s) involved. We began by establishing pertinent biochemical and biological phenotypes.
(ii) TK expression. Because of the established correlation between TK expression and neurovirulence in mice (4) Fig. 2A) , similar to those reported previously for virus RS6 (6), suggesting that the reduced neurovirulence of R13-1 was not caused by generalized replicative defects in mouse cells at the normal body temperature for mice.
Previous work with the intertypic viruses RE6 (18) and RS6 (6) indicated that reduced neurovirulence in mice correlates with an inability to replicate to wt virus titers in the mouse brain, and we expected that R13-1 would display similar replication deficiencies in these tissues. (Fig. 3) . The BamHI-digested DNAs of viruses Dl through D5 flanked by DNA of R13-1 and HG52 (HSV-2) are shown in Fig. 4A . By this analysis, it was found that a prominent genomic difference between these viruses and R13-1 was the presence of one of two novel high-molecularweight fragments (cxh or cxh', Fig. 3) . A Southern blot (Fig.  4B ) of the gel shown in Fig. 4A, probed To determine whether the four viruses just described displayed a recombinant genomic structure similar to any of the EcoRI-d-clone-derived viruses (Dl through D5), we analyzed their DNAs with the restriction enzyme BamHI (Fig. SA) . All of the viruses which did not exhibit neurovir- (14) .
b Genomic structure compared with that of R13-1, determined by analysis with BamHI. R, Recombinant; NR, identical to R13-1.
c As a control, unit-length R13-1 DNA was transfected alone onto rabbit skin cells. The resulting viruses were collectively inoculated into two mice, and after these mice succumbed to encephalitis, their brains were homoge nized and the resulting brain homogenates (cleared by centrifugation) were reinoculated into two more mice. The R13-1 virus used in this experiment was a stock prepared from the viruses recovered from the brain of one of the two mice which died from encephalitis. ulence characteristics resembling those of wt viruses (Table  3) displayed DNA profiles identical to that of R13-1 by this analysis (data not shown). In contrast, viruses 62-5, 62-6, and 62-10 demonstrated recombinant genotypes resembling those of viruses D2 and D3 derived from the EcoRI-d transfections. Southern blot analysis (Fig. 5B ) of the gel shown in Fig. 5A , probed with the EcoRI-d clone, confirmed this conclusion and also indicated that recombinant virus 62-6 was contaminated with parental virus R13-1. By this analysis, virus 62-9 resembles R13-1.
DISCUSSION
Using the intertypic recombinant virus R13-1, we identified a HSV gene function or functions which significantly affect the ability of HSV to elicit a fatal encephalitis after intracranial inoculation of mice. Since the virus into which this gene was placed already had the ability to replicate to high titer in the mouse brain, the function is not related to high-titer replication in this organ. Also important is the fact that the defect associated with this novel phenotype mapped to a region of the HSV genome not previously known to influence neurovirulence (0.079 to 0.143 m.u. In a general sense, the work presented in this report was a continuation of genetic and biological studies of the intertypic recombinant RS6. Our previous work with RS6 indicated that one or more genetic defects associated with its reduced neurovirulence reside within the region from 0.79 to 0.83 m.u. and that another lesion might also be present in the region from 0.11 to 0.14 m.u.; however, our attempts to increase the neurovirulence of RS6 with cloned HSV-1 DNA spanning this region were unsuccessful. A possible explanation for this result is that other genetic defects of RS6 masked the importance of this region. It has been observed that replacement of HSV-2 DNA with HSV-1 DNA in specific genomic regions is always linked to increased neu- rovirulence of intertypic recombinants selected for this phenotype (6, 17, 19) . Therefore, we reasoned that if we could isolate an RS6-derived recombinant virus in which all RS6 HSV-2-encoded regions were replaced with HSV-1 DNA except in the general region from 0.11 to 0.14 m.u., such a virus would display reduced neurovirulence. A virus with these characteristics is R13-1. We have assumed that because of the parentage of R13-1, the genetic lesion associated with reduced neurovirulence was inherited from RS6. Consistent with this idea is the fact that heterologous DNA replacement (HSV-2 DNA with HSV-1 DNA) in the general region from 0.11 to 0.14 m.u. was required to generate viruses with wt neurovirulence from both RS6 and R13-1. The nature of this genetic defect is not known, but several possible explanations for defects arising within intertypic recombinant viruses have been suggested (18) .
The genetic stability of the neurovirulence phenotype of R13-1 was somewhat different than in our previous studies. The extremely stable, low neurovirulence of viruses RE6 and RS6 (6, 19) after transfection and multiple brain passage was not found for virus R13-1. Here, neurovirulence increased 25-to 60-fold after transfection and two passages through mouse brains. Since a single genetic defect would increase the probability of producing neurovirulent revercritical regions or viral replication not resulting in the death of some cells. In any case, it seems likely that R13-1 can be studied in combination with a standard virus to define cells of the mouse brain crucial to the appearance of HSVinduced encephalitis. Finally, known genetic functions within the region from 0.079 to 0.143 m.u. can be considered. Although little is known about this region, three complementation groups (1-10, 1-6, and defined by temperature-sensitive mutations (2, 11, 12, 22) have been discerned, and several transcripts (20) map to this general area. The 1-10 gene is important early in the viral replication cycle and is essential for DNA synthesis (11), the 1-6 gene has recently been implicated in processing or packaging of viral DNA (15) , and the 1-26 gene appears necessary late in infection (2) . In addition, a structural gene, VP 18.8 (9) , is also encoded here. Whether these or other as yet unknown genes are concerned with the gene function described in this study can be investigated with additional, refined marker rescue experiments.
